Clinical Trials Browser

Terminated × NETWORK × Genitourinary × Clear all

NCT04871529 2024-12-30

Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)

Phase 2 Terminated

6 enrolled 12 charts

Urinary Bladder Neoplasms

NCT03869762 2024-09-25

DICE

Phase 2 Terminated

Neoplasm Metastasis, Prostatic Neoplasms

NCT00499174 2023-08-23

Observation or Radical Treatment in Patients With Prostate Cancer

Phase NA Terminated

180 enrolled 9 charts

Prostatic Neoplasms

NCT00352079 2023-08-04

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms

NCT00651326 2023-08-04

DART

Phase 3 Terminated

Prostatic Neoplasms

NCT00002668 2023-06-22

Pain Control in Patients With Recurrent or Metastatic Breast or Prostate Cancer

Phase NA Terminated

BreastGenitourinary

Breast Neoplasms, Pain, Prostatic Neoplasms

NCT00058448 2018-06-28

S0224, Docetaxel in Treating Patients With Locally Advanced or Metastatic Penile Cancer (TERMINATED)

Phase 2 Terminated

Penile Neoplasms

NCT00005047 2017-06-08

4B951, Combination Chemotherapy in Treating Patients With Bladder Cancer

Phase 3 Terminated

521 enrolled 18 charts

Urinary Bladder Neoplasms

NCT00022633 2016-08-11

S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract

Phase 2 Terminated

65 enrolled 14 charts

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00318110 2016-07-26

Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

Phase 2 Terminated

Carcinoma, Carcinoma, Renal Cell, Neoplasm Metastasis

NCT01603420 2016-03-14

External Beam Radiation With or Without Chemotherapy to Treat High Risk Prostate Cancer

Phase 2/3 Terminated

2 enrolled 8 charts

Neoplasms, Prostatic Neoplasms

NCT00288106 2015-09-30

S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT

Prostatic Neoplasms

NCT00023634 2015-03-06

S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer

Phase 1 Terminated

CNSGastrointestinalGenitourinaryGynecologic

Carcinoma, Ovarian Epithelial, Astrocytoma, Brain Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms

NCT00949962 2014-07-04

Post-operative or Early Salvage XRT and ADT for High Risk PCa

Phase 3 Terminated

Prostatic Neoplasms

NCT00087295 2012-11-02

S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium

Phase 2 Terminated

Urinary Bladder Neoplasms, Urethral Neoplasms

NCT00014586 2012-09-24

Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer

Phase 3 Terminated

Prostatic Neoplasms

NCT00042887 2012-09-24

Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms

NCT00003824 2012-03-09

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Phase 3 Terminated

Urinary Bladder Neoplasms

NCT00003640 2012-03-06

Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 2 Terminated

Urinary Bladder Neoplasms

NCT00003642 2012-03-06

Radiation Therapy and Chemotherapy Following Surgery in Treating Patients With Stage II or Stage III Bladder Cancer

Phase 2 Terminated

Urinary Bladder Neoplasms